These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19177539)

  • 1. Cardiovascular and gastrointestinal risks of nonsteroidal antiinflammatory drugs revisited: comment on the article by the American College of rheumatology Ad Hoc group on use of selective and nonselective nonsteroidal antiinflammatory drugs.
    Rothschild B
    Arthritis Rheum; 2009 Feb; 61(2):284-5, author reply 285-6. PubMed ID: 19177539
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper.
    American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs
    Arthritis Rheum; 2008 Aug; 59(8):1058-73. PubMed ID: 18668613
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of cyclooxygenase-2 inhibitors.
    Brophy JM
    Curr Opin Gastroenterol; 2007 Nov; 23(6):617-24. PubMed ID: 17906437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis.
    Pablos JL
    Arthritis Rheum; 2002 Nov; 46(11):3102. PubMed ID: 12428257
    [No Abstract]   [Full Text] [Related]  

  • 5. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
    Boers M
    Arthritis Rheum; 2007 Jan; 56(1):384; author reply 384. PubMed ID: 17195242
    [No Abstract]   [Full Text] [Related]  

  • 7. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
    Weber AA; Hohlfeld T; Harder S
    Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
    Hennekens CH; Borzak S
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the use of analgesics versus nonsteroidal anti-inflammatory drugs in rheumatic disorders: risks and benefits.
    McKellar G; Madhok R; Singh G
    Curr Opin Rheumatol; 2008 May; 20(3):239-45. PubMed ID: 18388512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of cox-2 selective nonsteroidal antiinflammatory drugs for postsurgical pain.
    Babul N; Sloan P; Lipman AG
    Anesth Analg; 2006 Feb; 102(2):645-6; author reply 646. PubMed ID: 16428581
    [No Abstract]   [Full Text] [Related]  

  • 17. The selection of a nonsteroidal antiinflammatory drug. Is there a difference?
    Willkens RF
    J Rheumatol Suppl; 1992 Nov; 36():9-12. PubMed ID: 1474545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk.
    U.S. Food and Drug Administration
    J Pain Palliat Care Pharmacother; 2005; 19(4):83-97. PubMed ID: 16431839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non steroidal anti-inflammatory drugs and rheumatic diseases].
    Cossermelli W; Pastor EH
    Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(2):115-24. PubMed ID: 7569599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.